Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $78.17
- Average 1Y price target
- $95.06+21.61%
- Agreement
- Good
Analysts agreement range is spread less than 15% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall2
- DCF1
- Return on equity2
- Return on assets2
- Debt / equity4
- P/E2
- P/B2
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 4 | $95.38 |
| Last quarter | 9 | $93.50 |
| Last year | 30 | $99.12 |
| All time | 67 | $90.26 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Truist Securities | maintain | Buy | Buy |
| Oct 12, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Oct 12, 2026 | Barclays | maintain | Overweight | Overweight |
| Sep 18, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Sep 3, 2026 | Truist Securities | maintain | Buy | Buy |
| Sep 2, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Sep 1, 2026 | Jefferies | upgrade | Hold | Buy |
| Aug 31, 2026 | Mizuho | downgrade | Outperform | Neutral |
| Aug 21, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Aug 13, 2026 | Truist Securities | maintain | Buy | Buy |
| Jul 22, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Jul 9, 2026 | Barclays | maintain | Overweight | Overweight |
| May 18, 2026 | Truist Securities | maintain | Buy | Buy |
| May 11, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Apr 21, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Apr 15, 2026 | Barclays | maintain | Overweight | Overweight |
| Mar 23, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Mar 18, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Mar 6, 2026 | UBS | maintain | Neutral | Neutral |
| Mar 5, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Mar 4, 2026 | Argus Research | upgrade | Hold | Buy |
| Feb 27, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Feb 3, 2026 | Barclays | maintain | Overweight | Overweight |
| Feb 2, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Jan 22, 2026 | UBS | maintain | Neutral | Neutral |
| Jan 22, 2026 | Barclays | maintain | Overweight | Overweight |
| Jan 20, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Dec 17, 2025 | UBS | maintain | Neutral | Neutral |
| Nov 24, 2025 | Citigroup | maintain | Neutral | Neutral |
| Nov 14, 2025 | Goldman Sachs | upgrade | Neutral | Buy |
| Nov 6, 2025 | UBS | maintain | Neutral | Neutral |
| Nov 6, 2025 | Barclays | maintain | Overweight | Overweight |
| Oct 22, 2025 | Jefferies | maintain | Hold | Hold |
| Oct 22, 2025 | BMO Capital | maintain | Outperform | Outperform |
| Oct 20, 2025 | Barclays | upgrade | Equal Weight | Overweight |
| Sep 25, 2025 | BMO Capital | maintain | Outperform | Outperform |
| Sep 24, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Sep 24, 2025 | Mizuho | maintain | Outperform | Outperform |
| Aug 26, 2025 | Barclays | maintain | Equal Weight | Equal Weight |
| Aug 4, 2025 | Citigroup | maintain | Neutral | Neutral |